T-Advisor, through its tool Market Opportunities, has detected the company AmerisourceBergen, listed in New York Stock Exchange (NYSE) as an opportunity for investment.
These are the main figures about performances and volatility in the last years:
The chart shows the evolution in the last year:
The technical analysis reveals also more data:
Finally, the risk analysis is as follows:
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel.
Company revenues increased last fiscal year 12.6%, till US$ 87,959 million, after a slight decrease the former year. This figures have to do with the strategic alliance with the German company Walgreens and Alliance Boots GmbH. However, net income dropped a 39,6%, till US$ 493,4 million. Share price have increased steadily and doubled the value since the beginning of 2012.